Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Отображение 4 из 8
Aseptic valves face exceptionally high demands within UltraClean and Aseptic processes. You can be assured that they all provide highest quality in terms of hygienic design and sustainability.
GEA Hilge offers a versatile range of centrifugal and positive displacement pumps for a wide variety of sensitive applications in the beverage, food and pharmaceutical industries.
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.
Когда южнокорейский производитель продуктов питания из растительного сырья Pulmuone поставил перед компанией GEA задачу разработать современный вариант традиционной холодной тягучей лапши (нэнмён), специалисты GEA по исследованиям и разработкам успешно справились с этой задачей. GEA помогла разработать продукт, который сейчас является коммерческим хитом и производится с меньшими затратами воды и электроэнергии, чем с использованием ранее существовавших методов. Результат соответствует традиционному характеру блюда, а также принципам поддержания здоровья, благополучия и устойчивого развития компании Pulmuone.
Инновационный процесс компании GEA является важной вехой в предварительной очистке такого биотоплива, как гидроочищенное растительное масло и экологически чистое авиационное топливо. Благодаря отказу от процесса отбеливания производители получают значительную экономию через снижение эксплуатационных расходов более чем на 50% и сокращение выбросов CO2 на 12%.